Cancer
| 3 min read
Backed by patient data and an AI platform, the BPGbio team presented promising results for a mitochondrial-targeted therapy in glioblastoma at AACR 2025.
| 4 min read
Cancer researchers in biotech and pharma highlight the clinical trials and developments they’re most excited about.
| 5 min read
Among the thrill of new results presented at the AACR 2025 conference, the specter of funding cuts to cancer research hung over the meeting.
Integrating multiplexed immunohistochemistry with spatial analysis offers a practical way to uncover tumor-immune dynamics.
| 2 min read
Collaboration to leverage Oxford Nanopore’s sequencing platform and Cepheid’s GeneXpert system to advance the field of sequencing for infectious diseases.
| 4 min read
Planned acquisition will strengthen the presence of the Healthcare business of Merck KGaA, Darmstadt, Germany, in the United States and expand reach of SpringWorks' therapeutic innovations to more patients with rare tumors worldwide
| 1 min read
ProBioGen announced the commercial launch of Ziihera®, a bispecific antibody for HER2-positive biliary tract cancer developed with its GlymaxX® technology.
| 2 min read
Autophagy in cancer is a double-edged sword: It protects cells from malignant transformation, but once tumors form, it helps them thrive.
| 7 min read
A targeted interleukin-12 gene therapy plus chemotherapy increased survival in advanced ovarian cancer, setting the stage for a new first-line drug.
Available on Demand
Learn how spatial profiling and patient-derived models uncover what drives therapy resistance in pancreatic cancer.
| 3 min read
Tamoxifen and a Mediterranean diet promoted bacterial communities that suppress breast tumor growth.
| 6 min read
ArsenalBio equips T cells with multiple weapons to identify, attack, and persist against tumors, bringing the power of CAR T cell technology to solid cancers.
| 6 min read
Judy Sebolt-Leopold and her team at MEKanistic Therapeutics developed a single molecule targeting two kinase enzymes that drive resistance to cancer therapies.
| 7 min read
Most cancer cells have the wrong number of chromosomes, known as aneuploidy. Scientists are finding ways to target this flaw with new treatments.
| 2 min read
New animal research suggests that the risk of developing cancer might be decided early in life.
| 2 min read
Researchers revealed for the first time that CAR T cells can transfer their CAR molecules to regular T cells in a process known as trogocytosis.
| 4 min read
Pfizer researchers are developing new treatments to target breast cancer tumors that flourish in the presence of hormones.
Available on Demand
Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
| 3 min read
Ovarian tumors are extremely difficult to get rid of. Scientists are figuring out how to leverage the immune system to help.
| 3 min read
An immune checkpoint inhibitor and chemotherapy extended progression-free survival in late-stage small cell bladder and prostate cancers.
Page 1 of 146 - 2909 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Decoding the tumor microenvironment with immune profiling
Integrating multiplexed immunohistochemistry with spatial analysis offers a practical way to uncover tumor-immune dynamics.
Exploring new frontiers in pancreatic cancer treatment with spatial biology
Learn how spatial profiling and patient-derived models uncover what drives therapy resistance in pancreatic cancer.
Advancing immuno-oncology research with cellular assays
Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
